CoChat
Sign Up
Cited by 267Autophagy in Disease and TherapyAtherosclerosis and Cardiovascular DiseasesTelomeres, Telomerase, and Senescence

The DOI matches its Crossref record; 72 of the 73 references it cites were found in a registry or an index.

Defective autophagy in vascular smooth muscle cells accelerates senescence and promotes neointima formation and atherogenesis

Open access
Grootaert, Mandy OJ, da Costa Martins, Paula A, Bitsch, Nicole, Pintelon, Isabel, De Meyer, Guido RY, Martinet, Wim, Schrijvers, Dorien M·2015·Autophagy
DOI 10.1080/15548627.2015.1096485PMC PMC4824610
Open this paper in CoChat — free accountOpen PDF

Abstract

Autophagy is triggered in vascular smooth muscle cells (VSMCs) of diseased arterial vessels. However, the role of VSMC autophagy in cardiovascular disease is poorly understood. Therefore, we investigated the effect of defective autophagy on VSMC survival and phenotype and its significance in the development of postinjury neointima formation and atherosclerosis. Tissue-specific deletion of the essential autophagy gene Atg7 in murine VSMCs (atg7−/− VSMCs) caused accumulation of SQSTM1/p62 and accelerated the development of stress-induced premature senescence as shown by cellular and nuclear hypertrophy, CDKN2A-RB-mediated G1 proliferative arrest and senescence-associated GLB1 activity. Transfection of SQSTM1-encoding plasmid DNA in Atg7+/+ VSMCs induced similar features, suggesting that accumulation of SQSTM1 promotes VSMC senescence. Interestingly, atg7−/− VSMCs were resistant to oxidative stress-induced cell death as compared to controls. This effect was attributed to nuclear translocation of the transcription factor NFE2L2 resulting in upregulation of several antioxidative enzymes. In vivo, defective VSMC autophagy led to upregulation of MMP9, TGFB and CXCL12 and promoted postinjury neointima formation and diet-induced atherogenesis. Lesions of VSMC-specific atg7 knockout mice were characterized by increased total collagen deposition, nuclear hypertrophy, CDKN2A upregulation, RB hypophosphorylation, and GLB1 activity, all features typical of cellular senescence. To conclude, autophagy is crucial for VSMC function, phenotype, and survival. Defective autophagy in VSMCs accelerates senescence and promotes ligation-induced neointima formation and diet-induced atherogenesis, implying that autophagy inhibition as therapeutic strategy in the treatment of neointimal stenosis and atherosclerosis would be unfavorable. Conversely, stimulation of autophagy could be a valuable new strategy in the treatment of arterial disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/15548627.2015.1096485

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Autophagy is defective in Atg7F/FTagln-Cre+ VSMCs. (A) VSMCs were isolated from the aorta of Atg7+/+Tagln-Cre+ (+/+) and Atg7F/FTagln-Cre+ (−/−) mice. Western blot analysis of ATG7, SQSTM1, ATG12–ATG5 and MAP1LC3B in untreated Atg7+/+ and atg7−/− VSMCs. ACTB was used as loading control. Bands are shown in duplicate. (B,C) Atg7+/+ and atg7−/− VSMCs were treated with EBSS for 48 h, followed by western blot analysis of MAP1LC3B (B) or transmission electron microscopy (C). Autophagic vesicles, characterized by incorporated dense degraded material and indicated by arrows, were quantified per cell (***, P < 0.001 vs. atg7−/−; ###, P < 0.001 vs. control; two-way ANOVA with genotype and treatment as category factors). Scale bar: 1 µm. The right panel shows a high-power image of autophagosomes in EBSS-treated Atg7+/+ VSMCs. Scale bar: 500 nm.
Figure 1. Autophagy is defective in Atg7F/FTagln-Cre+ VSMCs. (A) VSMCs were isolated from the aorta of Atg7+/+Tagln-Cre+ (+/+) and Atg7F/FTagln-Cre+ (−/−) mice. Western blot analysis of ATG7, SQSTM1, ATG12–ATG5 and MAP1LC3B in untreated Atg7+/+ and atg7−/− VSMCs. ACTB was used as loading control. Bands are shown in duplicate. (B,C) Atg7+/+ and atg7−/− VSMCs were treated with EBSS for 48 h, followed by western blot analysis of MAP1LC3B (B) or transmission electron microscopy (C). Autophagic vesicles, characterized by incorporated dense degraded material and indicated by arrows, were quantified per cell (***, P < 0.001 vs. atg7−/−; ###, P < 0.001 vs. control; two-way ANOVA with genotype and treatment as category factors). Scale bar: 1 µm. The right panel shows a high-power image of autophagosomes in EBSS-treated Atg7+/+ VSMCs. Scale bar: 500 nm.CC BY-NC · PubMed Central
Figure 2. Defective autophagy in VSMCs results in increased protection against oxidative stress-induced cell death. (A) Atg7+/+Tagln-Cre+ (+/+) and Atg7F/FTagln-Cre+ (−/−) VSMCs were treated with 25 µmol/l tBHP or 50 µg/ml oxLDL for 24 h (***, P < 0.001 vs. Atg7+/+; ###, P < 0.001 vs. control; n = 3 experiments in triplicate; two-way ANOVA with genotype and treatment as category factors and Dunnett Post Hoc test). To measure ROS production, Atg7+/+ and atg7−/− VSMCs were left untreated or treated with 100 µmol/l tBHP for 6 h, followed by a DCFDA staining (***, P < 0.001 vs. Atg7+/+; n = 200 cells/condition in duplicate; two-way ANOVA with genotype and treatment as category factors). (B) Atg7+/+ and atg7−/− VSMCs were treated with 10 µmol/l puromycin (PM) for 12 h or exposed to UV-irradiation for 10 min (NS, not significant vs. Atg7+/+; ###, P < 0.001 vs. control; n = 2 experiments in triplicate; two-way ANOVA with genotype and treatment as category factors). (C) Analysis of Gsta and Nqo1 expression in Atg7+/+ and atg7−/− VSMCs by real time RT-PCR (***, P < 0.001; n = 2 experiments in duplicate; Student t test) and western blotting. (D) Western blot analysis of NFE2L2 in cytoplasmic and nuclear fractions of Atg7+/+ and atg7−/− VSMCs. (E) atg7−/− VSMCs were transfected with 100 nmol/l siRNA against Nfe2l2 (siNfe2l2) or nontargeting siRNA (siCtrl). After 72 h, silencing efficiency was confirmed by western blotting by assessment of NFE2L2, GSTA and NQO1 expression and VSMCs were treated with tBHP or oxLDL for 24 h (***, P < 0.001 vs. siCtrl; ###, P < 0.001 vs. control; n = 3 experiments in duplicate; two-way ANOVA with genotype and treatment as category factors and Dunnett Post Hoc test).
Figure 2. Defective autophagy in VSMCs results in increased protection against oxidative stress-induced cell death. (A) Atg7+/+Tagln-Cre+ (+/+) and Atg7F/FTagln-Cre+ (−/−) VSMCs were treated with 25 µmol/l tBHP or 50 µg/ml oxLDL for 24 h (***, P < 0.001 vs. Atg7+/+; ###, P < 0.001 vs. control; n = 3 experiments in triplicate; two-way ANOVA with genotype and treatment as category factors and Dunnett Post Hoc test). To measure ROS production, Atg7+/+ and atg7−/− VSMCs were left untreated or treated with 100 µmol/l tBHP for 6 h, followed by a DCFDA staining (***, P < 0.001 vs. Atg7+/+; n = 200 cells/condition in duplicate; two-way ANOVA with genotype and treatment as category factors). (B) Atg7+/+ and atg7−/− VSMCs were treated with 10 µmol/l puromycin (PM) for 12 h or exposed to UV-irradiation for 10 min (NS, not significant vs. Atg7+/+; ###, P < 0.001 vs. control; n = 2 experiments in triplicate; two-way ANOVA with genotype and treatment as category factors). (C) Analysis of Gsta and Nqo1 expression in Atg7+/+ and atg7−/− VSMCs by real time RT-PCR (***, P < 0.001; n = 2 experiments in duplicate; Student t test) and western blotting. (D) Western blot analysis of NFE2L2 in cytoplasmic and nuclear fractions of Atg7+/+ and atg7−/− VSMCs. (E) atg7−/− VSMCs were transfected with 100 nmol/l siRNA against Nfe2l2 (siNfe2l2) or nontargeting siRNA (siCtrl). After 72 h, silencing efficiency was confirmed by western blotting by assessment of NFE2L2, GSTA and NQO1 expression and VSMCs were treated with tBHP or oxLDL for 24 h (***, P < 0.001 vs. siCtrl; ###, P < 0.001 vs. control; n = 3 experiments in duplicate; two-way ANOVA with genotype and treatment as category factors and Dunnett Post Hoc test).CC BY-NC · PubMed Central
Figure 3. Defective autophagy in VSMCs elicits cellular hypertrophy, and increases migration capacity and total collagen amount. (A) VSMCs isolated from Atg7+/+Tagln-Cre+ (+/+) and Atg7F/FTagln-Cre+ (−/−) aorta were labeled with calcein AM and visualized by confocal fluorescence microscopy. Scale bar: 10 µm. Cell size was measured using z-stack images (*, P < 0.05; n = 2 experiments; Student t test). (B) Thoracic aorta of Atg7+/+ and atg7−/− mice were stained with H&E to measure the width of the media (white arrows) (**, P < 0.01; n = 6 regions/aorta; Univariate). Scale bar: 25 µm. Note that the number of VSMC layers between Atg7+/+ and atg7−/− aorta was not different. (C) Migratory capacity of Atg7+/+ and atg7−/− VSMCs was analyzed using an Oris Migration Assay (***, P < 0.001; n = 2 experiments in triplicate; Student t test). Western blot analysis of TGFB and CXCL12 in Atg7+/+ and atg7−/− VSMCs. (D) Atg7+/+ and atg7−/− VSMCs were left untreated or treated with 10 ng/ml TGFB for 48 h and stained with Sirius red to examine total collagen amount (***, P < 0.001 vs. Atg7+/+; ###, P < 0.001 vs. control; n = 4 experiments in triplicate; two-way ANOVA with genotype and treatment as category factors).
Figure 3. Defective autophagy in VSMCs elicits cellular hypertrophy, and increases migration capacity and total collagen amount. (A) VSMCs isolated from Atg7+/+Tagln-Cre+ (+/+) and Atg7F/FTagln-Cre+ (−/−) aorta were labeled with calcein AM and visualized by confocal fluorescence microscopy. Scale bar: 10 µm. Cell size was measured using z-stack images (*, P < 0.05; n = 2 experiments; Student t test). (B) Thoracic aorta of Atg7+/+ and atg7−/− mice were stained with H&E to measure the width of the media (white arrows) (**, P < 0.01; n = 6 regions/aorta; Univariate). Scale bar: 25 µm. Note that the number of VSMC layers between Atg7+/+ and atg7−/− aorta was not different. (C) Migratory capacity of Atg7+/+ and atg7−/− VSMCs was analyzed using an Oris Migration Assay (***, P < 0.001; n = 2 experiments in triplicate; Student t test). Western blot analysis of TGFB and CXCL12 in Atg7+/+ and atg7−/− VSMCs. (D) Atg7+/+ and atg7−/− VSMCs were left untreated or treated with 10 ng/ml TGFB for 48 h and stained with Sirius red to examine total collagen amount (***, P < 0.001 vs. Atg7+/+; ###, P < 0.001 vs. control; n = 4 experiments in triplicate; two-way ANOVA with genotype and treatment as category factors).CC BY-NC · PubMed Central
Figure 4. Defective autophagy in VSMCs accelerates senescence. (A) Atg7+/+Tagln-Cre+ (+/+) and Atg7F/FTagln-Cre+ (−/−) VSMCs were treated with BrdU to examine proliferation (***P < 0.001; n = 9 counting regions of 300 cells/region/condition; Student t test). The size of BrdU-positive nuclei was measured to detect nuclear hypertrophy (**, P < 0.01; n = 50 nuclei; Student t test). (B) DNA cell cycle analysis of Atg7+/+ (blue) and atg7−/− (red) VSMCs. The bar graph shows the percentage of Atg7+/+ and atg7−/− nuclei in the G1 and G2/M phase of the cell cycle (**, P < 0.01; ***, P < 0.001; Student t test). (C) Atg7+/+ and atg7−/− VSMCs were stained with X-gal mixture for 24 h, followed by Nuclear Fast Red staining. Scale bar: 125 µm. The number of senescence-associated GLB1-positive VSMCs was quantified. (***, P < 0.001; n = 2 counting regions of 200 cells/region/condition; Student t test) (D) Western blot analysis of CDKN2A, phospho RB, total RB, acetylated TP53 and CDKN1A in Atg7+/+ and atg7−/− VSMCs. (E) Detection of DNA damage in Atg7+/+ and atg7−/− VSMCs by comet assay. Atg7+/+ VSMCs treated with .5 mmol/l H2O2 for 10 min were used as positive control. Scale bar: 25 µm.
Figure 4. Defective autophagy in VSMCs accelerates senescence. (A) Atg7+/+Tagln-Cre+ (+/+) and Atg7F/FTagln-Cre+ (−/−) VSMCs were treated with BrdU to examine proliferation (***P < 0.001; n = 9 counting regions of 300 cells/region/condition; Student t test). The size of BrdU-positive nuclei was measured to detect nuclear hypertrophy (**, P < 0.01; n = 50 nuclei; Student t test). (B) DNA cell cycle analysis of Atg7+/+ (blue) and atg7−/− (red) VSMCs. The bar graph shows the percentage of Atg7+/+ and atg7−/− nuclei in the G1 and G2/M phase of the cell cycle (**, P < 0.01; ***, P < 0.001; Student t test). (C) Atg7+/+ and atg7−/− VSMCs were stained with X-gal mixture for 24 h, followed by Nuclear Fast Red staining. Scale bar: 125 µm. The number of senescence-associated GLB1-positive VSMCs was quantified. (***, P < 0.001; n = 2 counting regions of 200 cells/region/condition; Student t test) (D) Western blot analysis of CDKN2A, phospho RB, total RB, acetylated TP53 and CDKN1A in Atg7+/+ and atg7−/− VSMCs. (E) Detection of DNA damage in Atg7+/+ and atg7−/− VSMCs by comet assay. Atg7+/+ VSMCs treated with .5 mmol/l H2O2 for 10 min were used as positive control. Scale bar: 25 µm.CC BY-NC · PubMed Central
Figure 5. SQSTM1 accumulation links defective VSMC autophagy to senescence. (A) Atg7+/+ VSMCs were transfected with 5 µg plasmid DNA encoding SQSTM1 (SQSTM1+). Four d after transfection, VSMCs were analyzed for SQSTM1, CDKN2A, phospho RB and total RB expression by western blotting. (B,C) SQSTM1 overexpressing VSMCs were incubated with BrdU (B) to examine proliferation capacity (***, P < 0.001; n = 2 counting regions of 1000 cells/region/condition in duplicate; Student t test) or (C) stained with X-gal mixture for 24 h to quantify the number of senescence-associated GLB1-positive VSMCs (***, P < 0.001; n = 3 counting regions of 150 cells/region/condition in duplicate; Student t test). Scale bar: 50 µm.
Figure 5. SQSTM1 accumulation links defective VSMC autophagy to senescence. (A) Atg7+/+ VSMCs were transfected with 5 µg plasmid DNA encoding SQSTM1 (SQSTM1+). Four d after transfection, VSMCs were analyzed for SQSTM1, CDKN2A, phospho RB and total RB expression by western blotting. (B,C) SQSTM1 overexpressing VSMCs were incubated with BrdU (B) to examine proliferation capacity (***, P < 0.001; n = 2 counting regions of 1000 cells/region/condition in duplicate; Student t test) or (C) stained with X-gal mixture for 24 h to quantify the number of senescence-associated GLB1-positive VSMCs (***, P < 0.001; n = 3 counting regions of 150 cells/region/condition in duplicate; Student t test). Scale bar: 50 µm.CC BY-NC · PubMed Central
Figure 6. Defective VSMC autophagy promotes upregulation of MMP9, TGFB and CXCL12, 5 d after ligation-induced injury. (A) The left common carotid artery (LCCA) of Atg7+/+Tagln-Cre+ (+/+) and Atg7F/FTagln-Cre+ (−/−) mice (n = 3) was ligated for 5 d. Gelatin zymographic analysis of the LCCA to detect MMP9 and MMP2 activity followed by densitometric analysis (***, P < 0.001; NS, not significant; Student t test). (B) Western blot analysis of the LCCA for TGFB, CXCL12 and GAPDH. Relative expression of TGFB/GAPDH and CXCL12/GAPDH was determined by densitometric analysis (*, P < 0.05; ***, P < 0.001; Student t test).
Figure 6. Defective VSMC autophagy promotes upregulation of MMP9, TGFB and CXCL12, 5 d after ligation-induced injury. (A) The left common carotid artery (LCCA) of Atg7+/+Tagln-Cre+ (+/+) and Atg7F/FTagln-Cre+ (−/−) mice (n = 3) was ligated for 5 d. Gelatin zymographic analysis of the LCCA to detect MMP9 and MMP2 activity followed by densitometric analysis (***, P < 0.001; NS, not significant; Student t test). (B) Western blot analysis of the LCCA for TGFB, CXCL12 and GAPDH. Relative expression of TGFB/GAPDH and CXCL12/GAPDH was determined by densitometric analysis (*, P < 0.05; ***, P < 0.001; Student t test).CC BY-NC · PubMed Central
Figure 7 (See previous page). Defective VSMC autophagy promotes neointima formation 5 wk after ligation-induced injury. (A,B) The left common carotid artery (LCCA) of Atg7+/+Tagln-Cre+ (+/+) (n = 10) and Atg7F/FTagln-Cre+ (−/−) mice (n = 12) was ligated for 5 wk. Sections of the LCCA were stained with anti-ACTA2 antibody (A) or Sirius red (B) to quantify the degree of stenosis and total collagen deposition, respectively. Scale bar: 100 µm. (**P < 0.01; *P < 0.05; Student t test). (C) Sections of the LCCA were immunostained for CDKN2A to quantify CDKN2A-positive nuclei (black arrowheads). Scale bar: 25 µm. (**, P < 0.01; Mann Whitney test). (D) The LCCA was stained for senescence-associated GLB1 activity ex vivo (right panel). Scale bar: 250 µm. Sections of the LCCA were then counterstained with periodic acid-Schiff (PAS) to identify senescent neointimal VSMCs (left panel). Note that the neointimal VSMCs are surrounded by a cage of PAS-positive basal lamina. Scale bar: 10 µm.
Figure 7 (See previous page). Defective VSMC autophagy promotes neointima formation 5 wk after ligation-induced injury. (A,B) The left common carotid artery (LCCA) of Atg7+/+Tagln-Cre+ (+/+) (n = 10) and Atg7F/FTagln-Cre+ (−/−) mice (n = 12) was ligated for 5 wk. Sections of the LCCA were stained with anti-ACTA2 antibody (A) or Sirius red (B) to quantify the degree of stenosis and total collagen deposition, respectively. Scale bar: 100 µm. (**P < 0.01; *P < 0.05; Student t test). (C) Sections of the LCCA were immunostained for CDKN2A to quantify CDKN2A-positive nuclei (black arrowheads). Scale bar: 25 µm. (**, P < 0.01; Mann Whitney test). (D) The LCCA was stained for senescence-associated GLB1 activity ex vivo (right panel). Scale bar: 250 µm. Sections of the LCCA were then counterstained with periodic acid-Schiff (PAS) to identify senescent neointimal VSMCs (left panel). Note that the neointimal VSMCs are surrounded by a cage of PAS-positive basal lamina. Scale bar: 10 µm.CC BY-NC · PubMed Central
Figure 8. Defective VSMC autophagy accelerates atherogenesis after 10 wk of western-type diet. (A) Atg7+/+Tagln-Cre+ apoe−/− (+/+) and Atg7F/FTagln-Cre+,apoe−/− (−/−) mice (n = 16) were fed a western-type diet for 10 wk. Sections of the brachiocephalic artery were stained with H&E to quantify plaque size and percentage of necrosis. (*, P<0.05; Student t test). (B to D) Consecutive sections were immunostained for cleaved CASP3 (B), LAMP2 (C) and ACTA2 (D) to measure the percentage of apoptosis (indicated by a black arrowhead in the high-power photograph of the boxed area in the left corner of each image), percentage of macrophages and fibrous cap thickness (indicated by black arrows), respectively (*, P < 0.05; Student t test (B); ***, P < 0.001; Student t test (C); *P < 0.05; n = 10 measurements/mouse, Repeated Measure (D)). (E) Consecutive sections were stained with Sirius red to quantify total collagen. (*, P < 0.05; Student t test). *, necrotic core. Scale bar: 100 µm.
Figure 8. Defective VSMC autophagy accelerates atherogenesis after 10 wk of western-type diet. (A) Atg7+/+Tagln-Cre+ apoe−/− (+/+) and Atg7F/FTagln-Cre+,apoe−/− (−/−) mice (n = 16) were fed a western-type diet for 10 wk. Sections of the brachiocephalic artery were stained with H&E to quantify plaque size and percentage of necrosis. (*, P<0.05; Student t test). (B to D) Consecutive sections were immunostained for cleaved CASP3 (B), LAMP2 (C) and ACTA2 (D) to measure the percentage of apoptosis (indicated by a black arrowhead in the high-power photograph of the boxed area in the left corner of each image), percentage of macrophages and fibrous cap thickness (indicated by black arrows), respectively (*, P < 0.05; Student t test (B); ***, P < 0.001; Student t test (C); *P < 0.05; n = 10 measurements/mouse, Repeated Measure (D)). (E) Consecutive sections were stained with Sirius red to quantify total collagen. (*, P < 0.05; Student t test). *, necrotic core. Scale bar: 100 µm.CC BY-NC · PubMed Central
Figure 9. Defective VSMC autophagy promotes formation of a thick fibrous cap and enhances total collagen deposition after 14 wk of western-type diet. (A) Atg7+/+Tagln-Cre+,apoe−/− (+/+) and Atg7F/FTagln-Cre+,apoe−/− (−/−) mice (n = 16) were fed a western-type diet for 14 wk. Sections of the brachiocephalic artery were stained with H&E to quantify plaque size and percentage of necrosis. (NS, not significant; Student t test). (B to D) Consecutive sections were immunostained for cleaved CASP3 (B), LAMP2 (C) and ACTA2 (D) to measure the percentage of apoptosis, percentage of macrophages and fibrous cap thickness (indicated by black arrows), respectively. (NS, not significant; Student t test (B,C); **, P < 0.01; n = 10 measurements/mouse, Repeated Measure (D)). (E) Consecutive sections were stained with Sirius red to quantify total collagen. (*, P < 0.05; Student t test). Scale bar: 100 µm. *, necrotic core.
Figure 9. Defective VSMC autophagy promotes formation of a thick fibrous cap and enhances total collagen deposition after 14 wk of western-type diet. (A) Atg7+/+Tagln-Cre+,apoe−/− (+/+) and Atg7F/FTagln-Cre+,apoe−/− (−/−) mice (n = 16) were fed a western-type diet for 14 wk. Sections of the brachiocephalic artery were stained with H&E to quantify plaque size and percentage of necrosis. (NS, not significant; Student t test). (B to D) Consecutive sections were immunostained for cleaved CASP3 (B), LAMP2 (C) and ACTA2 (D) to measure the percentage of apoptosis, percentage of macrophages and fibrous cap thickness (indicated by black arrows), respectively. (NS, not significant; Student t test (B,C); **, P < 0.01; n = 10 measurements/mouse, Repeated Measure (D)). (E) Consecutive sections were stained with Sirius red to quantify total collagen. (*, P < 0.05; Student t test). Scale bar: 100 µm. *, necrotic core.CC BY-NC · PubMed Central
Figure 10. Atherosclerotic plaques of Atg7F/FTagln-Cre+,apoe−/− mice show several features of VSMC senescence. (A) Sections of the aortic root were stained for senescence-associated (black arrowheads) and compared with serial TAGLN staining (not shown) to locate the fibrous caps. Scale bar: 10 µm. (B) Consecutive sections of the aortic root were double stained for phospho RB (red; white arrowheads) and ACTA2 (green). Scale bar: 25 µm (C) Sections of the brachiocephalic artery were double stained with phospho RB and periodic acid-Schiff (PAS) to quantify phospho RB-positive VSMC nuclei in the media (**, P < 0.01; Mann Whitney test). Scale bar: 50 µm.
Figure 10. Atherosclerotic plaques of Atg7F/FTagln-Cre+,apoe−/− mice show several features of VSMC senescence. (A) Sections of the aortic root were stained for senescence-associated (black arrowheads) and compared with serial TAGLN staining (not shown) to locate the fibrous caps. Scale bar: 10 µm. (B) Consecutive sections of the aortic root were double stained for phospho RB (red; white arrowheads) and ACTA2 (green). Scale bar: 25 µm (C) Sections of the brachiocephalic artery were double stained with phospho RB and periodic acid-Schiff (PAS) to quantify phospho RB-positive VSMC nuclei in the media (**, P < 0.01; Mann Whitney test). Scale bar: 50 µm.CC BY-NC · PubMed Central
Figure 11. Defective autophagy in macrophages triggers neither an antioxidative backup mechanism nor senescence. Bone marrow-derived macrophages were isolated from Atg7+/+Lysm-Cre+ (+/+) and Atg7F/FLysm-Cre+ (−/−) mice. (A) Western blot analysis of ATG7 and SQSTM1 in untreated Atg7+/+ and atg7−/− macrophages. (B) Real-time RT-PCR and western blot analysis of GSTA and NQO1 in Atg7+/+ and atg7−/− macrophages (NS, not significant; n = 2 experiments in duplicate; Student t test). (C) Atg7+/+ and atg7−/− macrophages were treated with 50 µmol/l tBHP for 24 h (***, P < 0.001 vs. Atg7+/+; ###, P < 0.001 vs. control; n = 2 experiments in duplicate; Two-way ANOVA with genotype and treatment as category factors). (D) Western blot analysis of NFE2L2 in cytoplasmic and nuclear fractions of Atg7+/+ and atg7−/− macrophages. (E) Proliferation of Atg7+/+ and atg7−/− macrophages were examined by BrdU incorporation assay (NS, not significant; n = 6 counting regions of 500 cells/region/condition; Student t test) (F) DNA cell cycle analysis of Atg7+/+ (blue) and atg7−/− (red) macrophages. The bar graph shows the percentage of Atg7+/+ and atg7−/− nuclei in G1 and G2/M phase of the cell cycle (NS, not significant; Student t test). (G) Western blot analysis of CDKN2A in Atg7+/+ and atg7−/− macrophages.
Figure 11. Defective autophagy in macrophages triggers neither an antioxidative backup mechanism nor senescence. Bone marrow-derived macrophages were isolated from Atg7+/+Lysm-Cre+ (+/+) and Atg7F/FLysm-Cre+ (−/−) mice. (A) Western blot analysis of ATG7 and SQSTM1 in untreated Atg7+/+ and atg7−/− macrophages. (B) Real-time RT-PCR and western blot analysis of GSTA and NQO1 in Atg7+/+ and atg7−/− macrophages (NS, not significant; n = 2 experiments in duplicate; Student t test). (C) Atg7+/+ and atg7−/− macrophages were treated with 50 µmol/l tBHP for 24 h (***, P < 0.001 vs. Atg7+/+; ###, P < 0.001 vs. control; n = 2 experiments in duplicate; Two-way ANOVA with genotype and treatment as category factors). (D) Western blot analysis of NFE2L2 in cytoplasmic and nuclear fractions of Atg7+/+ and atg7−/− macrophages. (E) Proliferation of Atg7+/+ and atg7−/− macrophages were examined by BrdU incorporation assay (NS, not significant; n = 6 counting regions of 500 cells/region/condition; Student t test) (F) DNA cell cycle analysis of Atg7+/+ (blue) and atg7−/− (red) macrophages. The bar graph shows the percentage of Atg7+/+ and atg7−/− nuclei in G1 and G2/M phase of the cell cycle (NS, not significant; Student t test). (G) Western blot analysis of CDKN2A in Atg7+/+ and atg7−/− macrophages.CC BY-NC · PubMed Central
Figure 12. Overview of the mechanisms by which defective VSMC autophagy accelerates senescence and promotes postinjury neointima formation and diet-induced atherogenesis. SQSTM1 accumulation in autophagy defective VSMCs triggers NFE2L2 activation and transcription of multiple antioxidative enzymes including GSTA and NQO1. Upregulation of GSTA and NQO1 promotes VSMC survival against oxidative stress under defective autophagy conditions. SQSTM1 accumulation in autophagy defective VSMCs triggers the development of stress-induced premature senescence. Autophagy defective VSMCs are characterized by CDKN2A-RB-mediated G1 proliferation arrest, increased migration and changes in VSMC phenotype. Enhanced migration is associated with increased secretion of MMP9, TGFB and CXCL12. The phenotype of autophagy defective VSMCs is defined by nuclear and cellular hypertrophy, and by increased collagen content. Defective autophagy in VSMCs accelerates postinjury neointima formation and diet-induced atherogenesis.
Figure 12. Overview of the mechanisms by which defective VSMC autophagy accelerates senescence and promotes postinjury neointima formation and diet-induced atherogenesis. SQSTM1 accumulation in autophagy defective VSMCs triggers NFE2L2 activation and transcription of multiple antioxidative enzymes including GSTA and NQO1. Upregulation of GSTA and NQO1 promotes VSMC survival against oxidative stress under defective autophagy conditions. SQSTM1 accumulation in autophagy defective VSMCs triggers the development of stress-induced premature senescence. Autophagy defective VSMCs are characterized by CDKN2A-RB-mediated G1 proliferation arrest, increased migration and changes in VSMC phenotype. Enhanced migration is associated with increased secretion of MMP9, TGFB and CXCL12. The phenotype of autophagy defective VSMCs is defined by nuclear and cellular hypertrophy, and by increased collagen content. Defective autophagy in VSMCs accelerates postinjury neointima formation and diet-induced atherogenesis.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 73 references

Research works printed but not linked: 3

  1. Grube E, 2004, Rev Cardiovasc Med, 5, S3
  2. Louis SF, 2010, Exp Clin Cardiol, 15, e75-85
  3. Seimon TA, 2009, J Clin Invest, 119, 886

Cited by

Sorted by citations

Related

See all

Metadata

Authors
Grootaert, M. O., da Costa Martins, P. A., Bitsch, N., Pintelon, I., De Meyer, G. R., Martinet, W., & Schrijvers, D. M.
Affiliations
  • University of Antwerp (BE)
  • Department of Cardiology; Cardiovascular Research Institute Maastricht; Maastricht, The Netherlands
  • Maastricht University (NL)
  • Laboratory of Physiopharmacology; University of Antwerp; Antwerp, Belgium
Corresponding author
Schrijvers, Dorien M
ORCID
Venue
Autophagy
Publisher
Informa UK Limited
Published
2015-11-02
Volume
11
Issue
11
Pages
2014-2032
ISSN
  • 1554-8627 (ISSN-L)
  • 1554-8635
DOI
10.1080/15548627.2015.1096485
PMC
PMC4824610
OpenAlex
W2200751652
Cited by
267
References
73
Citations by year
2026: 8 · 2025: 20 · 2024: 22 · 2023: 28 · 2022: 28 · 2021: 35 · 2020: 30 · 2019: 31 · 2018: 33 · 2017: 19 · 2016: 13
FWCI
17.00
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Autophagy (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
  • Digital Access to Libraries (submittedVersion, other-oa)
Funders
  • Fonds Wetenschappelijk Onderzoek (G044312N)
  • Vlaamse regering
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
  • Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
Keywords
vascular smooth muscle cells, cellular senescence, neointima formation, atherosclerosis, ATG7, p62, stress-induced premature senescence, Nrf2, oxidative stress resistance, GLB1, MMP-9, CXCL12, collagen deposition

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review